Home IPO candidate Atara shifts in deal with Memorial Sloan Kettering
 

Keywords :   


IPO candidate Atara shifts in deal with Memorial Sloan Kettering

2014-09-24 04:26:07| Biotech - Topix.net

Isaac Ciechanover's Atara Biotherapeutics has an option to license three experimental drug programs from Memorial Sloan Kettering Cancer Center. IPO-ready Atara Biotherapeutics could license from Memorial Sloan Kettering Cancer Center three treatments already in human clinical trials for certain cancers and persistent viral infections, the company said Tuesday.

Tags: deal candidate memorial ipo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11 (CFI-ZCT1J02)
27.11
27.11QUICKSILVER 8/S 130
27.11
27.11Laurene LaVallis Key To Our Love 7 US
27.11THE SCOPE AFTER DARK LP
27.11
27.11DVD
More »